Microglial transglutaminase 2 deficiency causes impaired synaptic remodelling and cognitive deficits in mice

Cong Liu1,2,3, Xing Gao1,4, Ruo-Xi Shi1,4

  • 1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Cell Proliferation
|March 6, 2023
PubMed

Insights

Microglial transglutaminase 2 (TGM2) is crucial for synaptic pruning and cognitive function. Its absence impairs neural development by down-regulating phagocytic genes in microglia.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia are the brain's primary source of transglutaminase 2 (TGM2).
  • The specific functions of microglial TGM2 in neural development and disease remain largely unknown.
  • Understanding these roles is critical for neurodevelopmental and neurodegenerative research.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of microglial TGM2 in the brain.
  • To determine the impact of TGM2 deficiency in microglia on neural development and function.
  • To identify molecular pathways regulated by microglial TGM2.

Main Methods:

  • Generation of a mouse model with Tgm2 specifically knocked out in microglia.
  • Utilized immunohistochemistry, Western blot, and qRT-PCR to assess TGM2 and synaptic marker expression.
  • Employed confocal imaging, immunofluorescence, behavioral analyses, and RNA sequencing to evaluate functional and molecular changes.

Main Results:

  • Microglial TGM2 deficiency led to impaired synaptic pruning and increased cognitive deficits.
  • Mice lacking microglial TGM2 exhibited reduced anxiety-like behaviors.
  • Key phagocytic genes (e.g., Cq1a, C1qb, Tim4) were significantly downregulated in TGM2-deficient microglia.

Conclusions:

  • Microglial TGM2 plays a novel and essential role in regulating synaptic remodeling during neural development.
  • TGM2 in microglia is vital for maintaining proper cognitive function and synaptic integrity.
  • These findings highlight microglial TGM2 as a potential therapeutic target for neurological disorders.

Related Concept Videos